- Home
- LGCL vs NEUE Comparison
LGCL vs NEUE Comparison
Compare LGCL & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- NEUE
- Stock Information
- Founded
- LGCL 2009
- NEUE 2015
- Country
- LGCL China
- NEUE United States
- Employees
- LGCL N/A
- NEUE N/A
- Industry
- LGCL
- NEUE
- Sector
- LGCL
- NEUE
- Exchange
- LGCL NYSE
- NEUE NYSE
- Market Cap
- LGCL 44.3M
- NEUE 42.7M
- IPO Year
- LGCL 2024
- NEUE 2021
- Fundamental
- Price
- LGCL $0.48
- NEUE $3.95
- Analyst Decision
- LGCL
- NEUE Hold
- Analyst Count
- LGCL 0
- NEUE 1
- Target Price
- LGCL N/A
- NEUE $7.00
- AVG Volume (30 Days)
- LGCL 401.3K
- NEUE 9.1K
- Earning Date
- LGCL 11-22-2024
- NEUE 11-07-2024
- Dividend Yield
- LGCL N/A
- NEUE N/A
- EPS Growth
- LGCL 11.49
- NEUE N/A
- EPS
- LGCL 0.14
- NEUE N/A
- Revenue
- LGCL $173,306,912.00
- NEUE $996,890,000.00
- Revenue This Year
- LGCL N/A
- NEUE N/A
- Revenue Next Year
- LGCL N/A
- NEUE $9.44
- P/E Ratio
- LGCL $3.52
- NEUE $1.12
- Revenue Growth
- LGCL N/A
- NEUE N/A
- 52 Week Low
- LGCL $0.47
- NEUE $3.79
- 52 Week High
- LGCL $5.00
- NEUE $16.59
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- NEUE 31.22
- Support Level
- LGCL N/A
- NEUE $3.99
- Resistance Level
- LGCL N/A
- NEUE $5.18
- Average True Range (ATR)
- LGCL 0.00
- NEUE 0.35
- MACD
- LGCL 0.00
- NEUE -0.15
- Stochastic Oscillator
- LGCL 0.00
- NEUE 7.24
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China.
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.